Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Sonoma Pharmaceuticals Inc. Stock

Price
Target price
€0.16

€0.16

9.930%
0.0164
9.930%
€1.00
 
15.04.24 / Tradegate WKN: A2PMPH / Symbol: SNOA / Name: Sonoma Pharmaceuticals / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Sonoma Pharmaceuticals Inc. in the next few years
Wizard

Sonoma Pharmaceuticals Inc. Stock

A very strong showing by Sonoma Pharmaceuticals Inc. today, with an increase of €0.016 (9.930%) compared to yesterday's price.
The community is currently still undecided about Sonoma Pharmaceuticals Inc. with 2 Buy predictions and 0 Sell predictions.
With a target price of 1 € there is potential for a 541.03% increase which would mean more than doubling the current price of 0.16 € for Sonoma Pharmaceuticals Inc..
Our community identified positive and negative aspects for Sonoma Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Unique positioning" as a plus for the Sonoma Pharmaceuticals Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
What does Sonoma Pharmaceuticals do?

Pros and Cons of Sonoma Pharmaceuticals Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-09

Sonoma Pharmaceuticals (SNOA), based on its recent financials, appears to be experiencing some financial challenges. The figures suggest that the company is struggling to maintain consistent financial performance, with the balance sheets and income statements indicating varying outcomes. However, it is essential to conduct a comprehensive evaluation of SNOA's financials to gain an accurate understanding of the company's overall financial standings. This analysis aims to present both the pros and cons of Sonoma Pharmaceuticals' financial position, enabling readers to make informed decisions about the company's future performance.

Improved Total Assets: Over the years, there has been an increase in the company's total assets. Between March 2020 and 2022, total assets grew from $14,561,000 to $18,845,000, indicating a potential increase in the overall value of the company.

Substantial Cash Reserves: As of 2022-03-31, the cash reported by Sonoma Pharmaceuticals was $7,396,000, signifying the availability of funds to invest in new projects, cover unforeseen expenses, or grow the company. A strong cash position adds financial stability to the company.

Show more

Comments

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating on the stock.
Ratings data for SNOA provided by MarketBeat
Show more

LADENBURG THALM/SH SH 
0
Report Share
05.09.23 Buy -82.89%
Show more
Not a member yet? Sign up for free!